Research led by Mayo Clinic Establishes Mortality Risk for Refractory Celiac Disease Patients

ROCHESTER, Minn — An international research team led by Mayo Clinic has developed a first-of-its-kind model to predict mortality in patients suffering from celiac disease (CD). The study, headed by Alberto Rubio-Tapia, M.D., Mayo Clinic gastroenterologist, established a five-year survival estimate for patients su ffering from refractory celiac disease, a rare and most severe form of [...]
Source: Mayo Clinic Research News - Category: Research Source Type: news